BUZZ-InMode slips after board committee rejects deal proposals** U.S.-listed shares of Israel-based medical technology firm InMode INMD.O fall 6% to $14.30 premarket
** INMD says a special committee of its board reviewed possible deal proposals but found none good enough
** The company says the committee has ended the process and will keep reviewing its business plans and use of cash
** Last month, Steel Partners offered $18 per share to acquire a 51% stake in InMode
** Earlier this month, co said it was evaluating potential strategic alternatives
** INMD fell 12% in 2025
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments